Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st December 2025
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| -5.3% | -1.9% | 7.4% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| 21.1% | 5.1% | 21.4% | 27.5% | 44.3% | -14.3% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| -5.3% | -1.9% | 7.4% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| 21.1% | 5.1% | 21.4% | 27.5% | 44.3% | -14.3% |
Rockwood Strategic employs a specialist value investing approach in the inefficient UK small cap market, targeting companies under £250m market cap trading below intrinsic value. The fund benefits from domestic investor exodus and depressed valuations that have created exceptional opportunities for patient capital. With 63% of assets concentrated in top 10 holdings, the strategy focuses on proven businesses with identifiable assets and mean reversion potential. The team takes an engaged approach, seeking influential stakes to drive operational improvements and value creation over 3-5 year time horizons. Key risks include continued outflows from UK small caps and restrictive interest rates, while catalysts include falling inflation, improving fiscal conditions, and structural market improvements. The portfolio is positioned for capital deployment with high conviction in current holdings across diverse sectors including financial services, technology, and industrials. Management targets 15% IRR returns through disciplined value investing combined with active engagement to unlock value in underappreciated UK companies.
UK small cap market offers exceptional value opportunities due to domestic investor exodus and depressed valuations, creating ideal conditions for concentrated value investing with engaged approach to drive 15% IRR returns.
Optimistic about capital deployment opportunities given depressed UK small cap valuations and improving macro conditions. Expects market conditions to become more conducive to value investing with falling rates and reduced competition in the space.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jan 12 2026 | 2025 Q4 | ADF.L, CAPD.L, CAU.L, CPI.L, CSC.L, EYE.L, FCH.L, FLO.L, FSJ.L, FTC.L, KOO.L, MERC.L, PEN.L, RKW.L, RST.L, SAA.L, STV.L, TET.L, TON.L, TRB.L, TRI.L, TUNE.L, VANQ.L, VLE.L | Engagement, Recovery, small caps, turnaround, United Kingdom, value | - | Fund employs a value investor mindset focused on free cash flow and margin of safety. Targets businesses trading below underlying value with mean reversion potential. Seeks companies with identifiable assets and proven business models at depressed valuations. Specialist focus on UK small company investments with market caps under £250m. Portfolio concentrated in companies with significant universe providing differentiated opportunities. Less competition in this space creates information advantages. Exclusively focused on UK listed companies benefiting from depressed valuations and domestic investor exodus. Sees scope for optimism with pension fund allocation improvements, falling interest rates, and multiple initiatives to improve UK market conditions. |
| Oct 20 2025 | 2025 Q3 | FLO LN, FSJ LN, VANQ | Recovery, small caps, turnaround, UK Equities, Value Investing |
VANQ FLO FSJ VANQ FLO FSJ |
Rockwood pursues activist-style investments in undervalued UK small caps, combining deep due diligence with engagement to unlock hidden value. The strategy targets turnarounds and balance sheet repair in companies like Vanquis Banking, RM Plc, and Flowtech Fluidpower. Managers see a depressed UK market as ripe for revaluation as inflation moderates and institutional flows return. |
| Jun 30 2025 | 2025 Q2 | FLO LN, FSJ LN | Capital Allocation, Discipline, mispricing, Patience, volatility |
FLO LN FSJ LN |
The letter stresses disciplined capital allocation in a market characterized by sharp style rotations and sentiment-driven volatility. Management emphasizes sticking to process, avoiding macro prediction, and exploiting mispricings created by short-term fear or exuberance. The outlook favors patient deployment of capital into undervalued situations as volatility creates repeated entry points. |
| May 1 2025 | 2025 Q1 | - | - | - | |
| Jan 30 2025 | 2024 Q4 | - | - | - | |
| Sep 30 2024 | 2024 Q3 | - | - | - | |
| Jun 30 2024 | 2024 Q2 | - | - | - | |
| Mar 31 2024 | 2024 Q1 | 6969 HK, AGFX LN, CITY, FCH LN, FSJ LN, FTC LN, RM/ LN, RST LN, SAA LN, STVG LN, TON LN, TRI LN | - | - | |
| Mar 31 2023 | 2023 Q1 | BUMP LN, CAU LN, FLO LN, GFRD LN, RM/ LN, SAA LN, TRI LN | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
Small CapsSmall caps getting strong start in 2026 supported by easing monetary conditions and constructive fiscal backdrop. Small caps more sensitive to economic cyclicality which is overdue for expansion. Expected to grow at better pace than large caps in 2026 after long period of underperformance. |
Value Growth Cyclical Monetary Policy Fiscal Policy |
United KingdomUK smaller companies experienced challenging conditions with government handling of Autumn Budget destroying corporate and consumer confidence. However, valuations remain attractive and sit well below long-term averages, with persistent M&A activity suggesting market players are taking notice. |
Small Caps Valuations Government Policy M&A | |
ValueManager emphasizes investing in controlled companies trading at significant discounts to NAV, with European holding companies showing discounts of 30-68%. The strategy focuses on securities mispricing where real value exists, contrasting with overvalued technology stocks. |
Discounts NAV Mispricing Undervalued Controlled | |
| 2025 Q3 |
HealthcareHealthcare was the strongest relative contributor in the quarter with holdings increasing nearly +16% compared to benchmark returns of roughly +12%. Exact Sciences was acquired for a significant premium by Abbott Laboratories resulting in an +86% return, while other strong performers included Tarsus Pharmaceuticals, Glaukos following approval of a new product, Penumbra, and Repligen driven by strong earnings results. |
M&A Product Approval Earnings Biotech |
| 2025 Q2 |
Discipline |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | Fund Letters | Richard Staveley | VANQ | Vanquis Banking Group plc | Financials | Consumer Finance | Bull | NYSE | consumer finance, cost-cutting, Deposits, Regulation, Rote, turnaround, valuation | Login |
| Oct 20, 2025 | Fund Letters | Richard Staveley | FLO | Flowtech Fluidpower plc | Industrials | Industrial Distribution | Bull | NYSE | Digital transformation, EBITDA, Industrial distribution, insider ownership, Margin recovery, restructuring | Login |
| Oct 20, 2025 | Fund Letters | Richard Staveley | FSJ | James Fisher & Sons plc | Industrials | Engineering & Marine Services | Bull | NYSE | asset sales, Defense, deleveraging, engineering, Margins, recovery, restructuring | Login |
| Oct 20, 2025 | Fund Letters | Richard Staveley | VANQ | Vanquis Banking Group plc | Financials | Consumer Finance | Bull | NYSE | consumer finance, cost-cutting, Deposits, Regulation, Rote, turnaround, valuation | Login |
| Oct 20, 2025 | Fund Letters | Richard Staveley | FLO | Flowtech Fluidpower plc | Industrials | Industrial Distribution | Bull | NYSE | Digital transformation, EBITDA, Industrial distribution, insider ownership, Margin recovery, restructuring | Login |
| Oct 20, 2025 | Fund Letters | Richard Staveley | FSJ | James Fisher & Sons plc | Industrials | Engineering & Marine Services | Bull | NYSE | asset sales, Defense, deleveraging, engineering, Margins, recovery, restructuring | Login |
| Jun 30, 2025 | Fund Letters | Richard Staveley | FLO LN | Flowtech Fluidpower plc | Industrials | Industrial Distribution | Bull | New York Stock Exchange | Acquisitions, Distribution, Fluidpower, Hydraulics, Industrials, Smallcap, turnaround, UK | Login |
| Jun 30, 2025 | Fund Letters | Richard Staveley | FSJ LN | James Fisher & Sons plc | Industrials | Marine Freight & Logistics | Bull | New York Stock Exchange | Defence, deleveraging, energy, engineering, Marine, Smallcap, Transportation, turnaround, UK | Login |
| TICKER | COMMENTARY |
|---|---|
| CPI.L | Capita represents 9.5% portfolio weighting with £489m market cap in Business Services sector. |
| FSJ.L | James Fisher & Sons provides specialist engineering services to energy, defence, renewables and marine markets. 175-year-old business with 2367 employees across 18 countries. Recovery opportunities include new management team delivering margin/return recovery and stronger balance sheet driving re-rating to historical averages. Target recovery £75m Ebitda with upside potential >200%. |
| FTC.L | December saw the GA-Courtenay Special Situations fund (USD I) appreciate by +6.3%, resulting in a return for 2025 of +6.5%. The positive result was primarily driven by price appreciation in Echostar and Filtronic, the fund's largest two positions, and both publically listed proxies for SpaceX. |
| RKW.L | Rockwood Strategic Plc is the fund itself, targeting 15% IRR investments over the long-term with a concentrated portfolio approach. |
| SAA.L | M&C Saatchi represents 5.4% portfolio weighting with £164m market cap in Media sector, currently in Realisation stage with 5.1% Rockwood/Harwood stake. |
| VANQ.L | Vanquis Banking Group represents 7.7% portfolio weighting with £302m market cap in Financial Services sector. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||